JPRN-UMIN000019325已完成未知
Enzalutamide treatment sensitivity recovery effect of docetaxel treatment after relapse of enzalutamide treatment for castration-resistant prostate cancer patients - ESRED study
Department of Urology Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital0 个研究点目标入组 20 人开始时间: 2015年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Patients treated by chemotherapy 2. Patients judged to be inappropriate to perform this study by investigator
研究者
相似试验
已完成
不适用
Investigation of clinical efficacy of Enzalutamide and its predictive factors in CRPC patientscastration resistant prostate cancerJPRN-UMIN000015996Keio University School of Medicine50
已完成
4 期
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer PatientsProstate CancerNCT01995513Pfizer509
进行中（未招募）
1 期
Enzalutamide Treatment of Metastatic Castration-Resistant Prostate Cancer Patients after Abiraterone AcetateEUCTR2013-002271-17-DEAstellas Pharma Europe B.V.200
进行中（未招募）
不适用
A trial of the combination treatment enzalutamide and AZD5363 for patients with advanced prostate cancer.EUCTR2013-004091-34-GBThe Royal Marsden NHS Foundation Trust136
招募中
不适用
A study to Determine Enzalutamide Long-term safety and efficacy after anti-androgen therapy for CRPC.Castration resistant prostate cancer (CRPC)JPRN-UMIN000019855Osaka University Graduate School Of Medicine200